Literature DB >> 16628717

Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.

Elisabetta Calistri1, Mario Tiribelli, Marta Battista, Angela Michelutti, Mario Corbellino, Pierluigi Viale, Renato Fanin, Daniela Damiani.   

Abstract

Epstein-Barr virus (EBV) infection and reactivation is an increasing complication in immune deficient patients, particularly after allogeneic hematopoietic stem cell transplantation (HSCT). Therapy with anti-thymocyte globulin (ATG) is associated with higher incidence of EBV-related disease in HSCT patients, but this risk is not documented in patients receiving ATG for severe aplastic anemia (SAA). We describe the case of a patient who developed an EBV infection, with the clinical features of an infectious mononucleosis, after immune suppression with cyclosporine and two courses of ATG for SAA. 2006 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16628717     DOI： 10.1002/ajh.20560

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  9 in total

1.  Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.

Authors:  George M Viola; Youli Zu; Kelty R Baker; Saima Aslam
Journal:  Med Oncol       Date:  2010-08-03       Impact factor: 3.064

2.  Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.

Authors:  Phillip Scheinberg; Steven H Fischer; Li Li; Olga Nunez; Colin O Wu; Elaine M Sloand; Jeffrey I Cohen; Neal S Young; A John Barrett
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

Review 3.  Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.

Authors:  Ryota Nakanishi; Mitsuaki Ishida; Keiko Hodohara; Hiroko Okuno; Miyuki Yoshii; Akiko Horinouchi; Ayaka Shirakawa; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.

Authors:  Diana Stauch; Annelie Dernier; Elizabeth Sarmiento Marchese; Kristina Kunert; Hans-Dieter Volk; Johann Pratschke; Katja Kotsch
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

Review 5.  Concurrent Epstein-Barr virus associated NK/T cell lymphoma after immunosuppressive therapy for aplastic anemia: report of a case and review of literature.

Authors:  Guangli Yin; Ying Ni; Zhengrui Xiao; Guangsheng He; Kourong Miao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia.

Authors:  Hiroko Sugimoto-Sekiguchi; Haruko Tashiro; Ryosuke Shirasaki; Tomio Arai; Tadashi Yamamoto; Yoko Oka; Nobu Akiyama; Kazuo Kawasugi; Naoki Shirafuji
Journal:  Case Rep Gastrointest Med       Date:  2012-09-23

7.  Successful renal transplantation after recovery from acute disseminated encephalomyelitis in a child with end-stage renal disease.

Authors:  Guruprasad P Bhosale; Veena R Shah; Hargovind L Trivedi
Journal:  Indian J Crit Care Med       Date:  2010-04

8.  Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A.

Authors:  Tohru Takahashi; Yumiko Maruyama; Mayuko Saitoh; Hideto Itoh; Mitsuru Yoshimoto; Masayuki Tsujisaki
Journal:  Case Rep Hematol       Date:  2015-09-03

9.  Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.

Authors:  Kiyomi Mashima; Shingo Yano; Hiroki Yokoyama; Takeshi Saito; Tomohito Machishima; Takaki Shimada; Yuichi Yahagi; Shinobu Takahara; Katsuki Sugiyama; Yoji Ogasawara; Jiro Minami; Yutaro Kamiyama; Atsushi Katsube; Kazuhito Suzuki; Sayaka Ohshima; Hisashi Yamada; Noriko Usui; Keisuke Aiba
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.